Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Neogen Corporation - Key Facts
Neogen Corporation - Key Employees
Neogen Corporation - Key Employee Biographies
Neogen Corporation - Major Products and Services
Neogen Corporation - History
Neogen Corporation - Company Statement
Neogen Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Neogen Corporation - Business Description
Neogen Corporation - SWOT Analysis
SWOT Analysis - Overview
Neogen Corporation - Strengths
Strength - Diverse Product Lines
Strength - Strong Research and Development Activities
Strength - Increasing Liquidity
Neogen Corporation - Weaknesses
Weakness - Increasing Operating Expenses
Neogen Corporation - Opportunities
Opportunity - Strategic Acquisitions
Opportunity - New Product Launches
Opportunity - Growing Veterinary Market
Neogen Corporation - Threats
Threat - Rapid Technological Change
Threat - Stringent Government Regulations
Threat - Highly Competitive Market
Neogen Corporation - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company's Lifesciences Financial Deals and Alliances
Neogen Corporation, Medical Equipment, Deals By Year, 2006 to YTD 2012
Neogen Corporation, Medical Equipment, Deals By Type, 2006 to YTD 2012
Neogen Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Neogen Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Neogen Corporation, Recent Deals Summary
Section 5 – Company's Recent Developments
Neogen Corporation, Recent Developments
06/08/2012: Neogen Launches ANSR For Listeria
24/07/2012: Neogen Reports Revenue Of $184m In Fiscal 2012
18/07/2012: Neogen Receives AOAC Approval For Soleris TVC Test
27/03/2012: Neogen Reports Revenue Of $44.9m In Q3 Fiscal 2012
22/12/2011: Neogen Reports Revenue Of $44.9m In Q2 Fiscal 2012
27/09/2011: Neogen Reports Revenue Of $45.7m In Q1 Fiscal 2012
26/07/2011: Neogen Reports Total Revenue Of $172.7m In Fiscal Year Ended 2011
26/05/2011: Genetic Technologies Files New Patent Infringement Suit In US
17/05/2011: Neogen Elects William Boehm To Board Of Directors
22/03/2011: Neogen Reports Net Income Of $4.9m In Q3 Fiscal Year Ended 2011
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Neogen Corporation, Key Facts
Neogen Corporation, Key Employees
Neogen Corporation, Key Employee Biographies
Neogen Corporation, Major Products and Services
Neogen Corporation, History
Neogen Corporation, Other Locations
Neogen Corporation, Subsidiaries
Neogen Corporation, Key Competitors
Neogen Corporation, Ratios based on current share price
Neogen Corporation, Annual Ratios
Neogen Corporation, Interim Ratios
Neogen Corporation, Medical Equipment, Deals By Year, 2006 to YTD 2012
Neogen Corporation, Medical Equipment, Deals By Type, 2006 to YTD 2012
Neogen Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Neogen Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Neogen Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Neogen Corporation, Performance Chart (2008 - 2012)
Neogen Corporation, Ratio Charts
Neogen Corporation, Medical Equipment, Deals By Year, 2006 to YTD 2012
Neogen Corporation, Medical Equipment, Deals by Type, 2006 to YTD 2012
Neogen Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Neogen Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2006 to YTD 2012 35